Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ALGN — Align Technology Inc

CIK 1423053 MIAMI, FL
Back to ALGN Full portfolio

Position in ALGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$125,148,185
+$43,879,762 QoQ
Shares Held
730,025
+40.3% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALGN Over Time

Shares Held

Position Value (USD)

Derivatives in ALGN

reported options exposure · as of Mar 31, 2026
CallValue
$23,725,912
CallShares
138,400
PutValue
$12,188,673
PutShares
71,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Instruments & Supplies

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $1,983,617,750 across 42 Medical Instruments & Supplies names. ALGN ranks #5 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ISRG
Intuitive Surgical Inc
 1,356,011 $625,107,510
2 TFX
Teleflex Inc
 1,171,096 $140,074,791
3 BDX
Becton Dickinson & Co
 829,501 $130,422,441
4 RGEN
Repligen Corp
 1,099,181 $129,505,505
5 ALGN
Align Technology Inc
This page 		730,025 $125,148,185
6 NVST
Envista Holdings Corp
 4,584,572 $116,310,591
7 HOLX
HOLOGIC INC
 1,090,660 $82,442,989
8 WST
West Pharmaceutical Services Inc
 323,587 $81,103,845

All Filings in ALGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $23,725,912 138,400
2026-03-31 $125,148,185 730,025
2026-03-31 $12,188,673 71,100
2025-12-31 $16,957,890 108,600
2025-12-31 $81,268,423 520,451
2025-12-31 $35,805,195 229,300
2025-09-30 $40,997,028 327,400
2025-09-30 $15,189,186 121,300
2025-09-30 $23,114,484 184,591
2025-06-30 $30,576,795 161,500
2025-06-30 $316,853,599 1,673,552
2025-06-30 $28,588,830 151,000
2025-03-31 $32,613,958 205,300
2025-03-31 $45,497,504 286,400
2025-03-31 $255,865,634 1,610,636
2024-12-31 $23,061,206 110,600
2024-12-31 $60,718,112 291,200
2024-12-31 $364,856,218 1,749,826
2024-09-30 $41,886,504 164,700
2024-09-30 $43,539,584 171,200
2024-09-30 $394,582,311 1,551,519
2024-06-30 $47,875,569 198,300
2024-06-30 $201,476,473 834,513
2024-06-30 $55,553,043 230,100
2024-03-31 $58,107,424 177,200
2024-03-31 $89,128,656 271,800
2024-03-31 $195,773,814 597,017
2023-12-31 $100,941,600 368,400
2023-12-31 $109,106,800 398,200
2023-12-31 $34,746,488 126,812
2023-09-30 $67,597,848 221,400
2023-09-30 $55,507,176 181,800
2023-09-30 $135,400,565 443,471
2023-06-30 $97,710,732 276,300
2023-06-30 $89,470,920 253,000
2023-06-30 $172,454,667 487,656
2023-03-31 $115,946,580 347,000
2023-03-31 $138,968,826 415,900
2023-03-31 $451,151,149 1,350,186
2022-12-31 $93,787,230 444,700
2022-12-31 $59,642,520 282,800
2022-12-31 $84,889,991 402,513
2022-09-30 $108,007,865 521,500
2022-09-30 $23,737,498 114,613
2022-09-30 $44,238,696 213,600
2022-06-30 $115,447,626 487,800
2022-06-30 $125,766,438 531,400
2022-06-30 $7,982,169 33,727
2022-03-31 $53,410,872 122,502
2022-03-31 $313,396,800 718,800

Report a Problem

Category
Description
Email (optional, for follow-up)